Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham P Collins

Showing results (61-70 of 164) with videos related to

Pageof 17
Sort By:
British Journal of Haematology|April 1, 2022
Management of children and adults with all stages of nodular lymphocyte predominant Hodgkin lymphoma - All StAGEs: A consensus-based position paper from the Hodgkin lymphoma subgroup of the UK National Cancer Research InstituteAnanth Shankar, Georgina W Hall, Pam McKay, et al.
British Journal of Haematology|July 31, 2015
Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with de novo diffuse large B cell lymphomaToby A Eyre, Richard Salisbury, David W Eyre, et al.
American Journal of Hematology|February 27, 2015
Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant Hodgkin lymphoma: long-term outcomes from a 30-year experienceToby A Eyre, Kevin Gatter, Graham P Collins, et al.
Clinical Pharmacology and Therapeutics|June 2, 2019
Population Pharmacokinetic Modeling and Exposure-Response Assessment for the Antibody-Drug Conjugate Brentuximab Vedotin in Hodgkin's Lymphoma in the Phase III ECHELON-1 StudyAjit Suri, Diane R Mould, Gregory Song, et al.
Scientific American|May 21, 2011
Radical energy solutionsGraham P Collins, David Biello, J R Minkel, et al.
British Journal of Haematology|February 28, 2015
A phase II trial of AZD1152 in relapsed/refractory diffuse large B-cell lymphomaGraham P Collins, Toby A Eyre, Kim M Linton, et al.
Advances in Hematology|December 6, 2017
Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma PatientsKamel Ait-Tahar, Amanda P Anderson, Martin Barnardo, et al.
British Journal of Haematology|May 6, 2020
Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID-19 pandemicJohn Willan, Andrew J King, Faouzi Djebbari, et al.
Scientific American|December 10, 2002
Scientific American 50Mark Alpert, Ashley Steven, Graham P Collins, et al.
British Journal of Haematology|October 15, 2013
Guideline on the management of primary resistant and relapsed classical Hodgkin lymphomaGraham P Collins, Anne N Parker, Christopher Pocock, et al.
Pageof 17

Showing results (61-70 of 164) with videos related to

Sort By:
Pageof 17
British Journal of Haematology|April 1, 2022
Management of children and adults with all stages of nodular lymphocyte predominant Hodgkin lymphoma - All StAGEs: A consensus-based position paper from the Hodgkin lymphoma subgroup of the UK National Cancer Research InstituteAnanth Shankar, Georgina W Hall, Pam McKay, et al.
British Journal of Haematology|July 31, 2015
Results of a large retrospective analysis of the effect of intended dose intensity of R-CHOP on outcome in a cohort of consecutive, unselected elderly patients with de novo diffuse large B cell lymphomaToby A Eyre, Richard Salisbury, David W Eyre, et al.
American Journal of Hematology|February 27, 2015
Incidence, management, and outcome of high-grade transformation of nodular lymphocyte predominant Hodgkin lymphoma: long-term outcomes from a 30-year experienceToby A Eyre, Kevin Gatter, Graham P Collins, et al.
Clinical Pharmacology and Therapeutics|June 2, 2019
Population Pharmacokinetic Modeling and Exposure-Response Assessment for the Antibody-Drug Conjugate Brentuximab Vedotin in Hodgkin's Lymphoma in the Phase III ECHELON-1 StudyAjit Suri, Diane R Mould, Gregory Song, et al.
Scientific American|May 21, 2011
Radical energy solutionsGraham P Collins, David Biello, J R Minkel, et al.
British Journal of Haematology|February 28, 2015
A phase II trial of AZD1152 in relapsed/refractory diffuse large B-cell lymphomaGraham P Collins, Toby A Eyre, Kim M Linton, et al.
Advances in Hematology|December 6, 2017
Sp17 Protein Expression and Major Histocompatibility Class I and II Epitope Presentation in Diffuse Large B Cell Lymphoma PatientsKamel Ait-Tahar, Amanda P Anderson, Martin Barnardo, et al.
British Journal of Haematology|May 6, 2020
Assessing the impact of lockdown: Fresh challenges for the care of haematology patients in the COVID-19 pandemicJohn Willan, Andrew J King, Faouzi Djebbari, et al.
Scientific American|December 10, 2002
Scientific American 50Mark Alpert, Ashley Steven, Graham P Collins, et al.
British Journal of Haematology|October 15, 2013
Guideline on the management of primary resistant and relapsed classical Hodgkin lymphomaGraham P Collins, Anne N Parker, Christopher Pocock, et al.
Pageof 17